Illumina Company Profile (NASDAQ:ILMN)

About Illumina

Illumina, Inc. (Illumina) offers sequencing and array-based solutions for genetic analysis. The Company's products and services serve customers in a range of markets, enabling the adoption of genomic solutions in research and clinical settings. The Company's customers include genomic research centers, academic institutions, government laboratories and hospitals, as well as pharmaceutical, biotechnology, agrigenomics and commercial molecular diagnostic laboratories, and consumer genomics companies. It provides sample-to-answer solutions to its customers in various areas of translational and clinical genomics, such as reproductive and genetic health, and oncology. It provides reproductive-health solutions, including preimplantation genetic screening and diagnosis, noninvasive prenatal testing, and neonatal and genetic health testing. It also provides whole-genome sequencing, genotyping and NIPT services. It has operations in the United States, Europe, Asia-Pacific and other markets.

Industry, Sector and Symbol:

• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: Life Sciences Tools & Services
• Exchange: NASDAQ
• Symbol: ILMN
• CUSIP: 45232710

Key Metrics:

• Previous Close: $178.47
• 50 Day Moving Average: $170.83
• 200 Day Moving Average: $154.22
• 52-Week Range: $127.10 - $196.47
• Trailing P/E Ratio: 61.12
• Foreward P/E Ratio: 43.42
• P/E Growth: 3.18
• Market Cap: $26.16B
• Outstanding Shares: 146,600,000
• Beta: 0.73

Profitability:

• Net Margins: 18.73%
• Return on Equity: 23.69%
• Return on Assets: 12.46%

Debt:

• Debt-to-Equity Ratio: 0.48%
• Current Ratio: 3.69%
• Quick Ratio: 3.15%

Additional Links:

• Visit Illumina's Official Website
• View ILMN on Google Finance
• View ILMN on Yahoo Finance
• View ILMN's Company Profile on Reuters
• Search for Illumina Inc. on Google

Companies Related to Illumina:

• Teva Pharmaceutical Industries Ltd (NYSE:TEVA)
• Express Scripts Holding (NASDAQ:ESRX)
• Stryker Corp. (NYSE:SYK)
• Regeneron Pharmaceuticals (NASDAQ:REGN)
• Aetna (NYSE:AET)
• Becton Dickinson and (NYSE:BDX)
• McKesson Corp. (NYSE:MCK)
• Takeda Pharmaceutical (OTCMKTS:TKPYY)
• Astellas Pharma (OTCMKTS:ALPMY)
• Anthem (NYSE:ANTM)

Earnings

Earnings History for Illumina (NASDAQ:ILMN)

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call	Details
10/18/2016
7/26/2016	Q2	$0.73	$0.86	$31.91 million	$600.00 million	View	Listen
5/3/2016	Q1	$0.74	$0.71	$596.33 million	$572.00 million	View	Listen
2/2/2016	Q415	$0.82	$0.70	$576.39 million	$591.50 million	View	Listen
10/20/2015	Q315	$0.79	$0.80	$568.60 million	$550.00 million	View	Listen
7/21/2015	Q215	$0.77	$0.80	$541.05 million	$539.00 million	View	Listen
4/21/2015	Q115	$0.72	$0.91	$524.35 million	$539.00 million	View	Listen
1/27/2015	Q414	$0.77	$0.87	$503.83 million	$512.00 million	View	Listen
10/20/2014	Q314	$0.56	$0.77	$451.20 million	$481.00 million	View	Listen
7/23/2014	Q214	$0.50	$0.57	$426.50 million	$448.00 million	View	Listen
4/22/2014	Q114	$0.45	$0.46	$391.50 million	$421.00 million	View	Listen
1/28/2014	Q413	$0.44	$0.45	$382.06 million	$387.00 million	View	Listen
10/21/2013	Q313	$0.40	$0.45	$343.42 million	$357.00 million	View	Listen
7/23/2013	Q2 2013	$0.40	$0.43	$331.77 million	$346.09 million	View	Listen
4/22/2013	Q1 2013	$0.39	$0.46	$310.64 million	$330.96 million	View	Listen
1/28/2013	Q4 2012	$0.41	$0.42	$303.13 million	$309.30 million	View	Listen
10/23/2012		$0.39	$0.41			View	N/A
7/24/2012		$0.36	$0.40			View	N/A
4/23/2012		$0.32	$0.36			View	N/A
2/7/2012		$0.30	$0.35			View	N/A
10/25/2011		$0.23	$0.22			View	N/A
4/26/2011		$0.31	$0.35			View	N/A
2/8/2011		$0.29	$0.29			View	N/A

(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Illumina (NASDAQ:ILMN)

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2016	7	$0.67	$0.86	$0.77
Q2 2016	7	$0.72	$0.91	$0.84
Q3 2016	5	$0.88	$0.93	$0.91
Q4 2016	5	$0.95	$1.04	$1.01
Q1 2017	2	$0.85	$1.06	$0.96
Q2 2017	2	$0.95	$1.07	$1.01
Q3 2017	1	$1.10	$1.10	$1.10
Q4 2017	1	$1.13	$1.13	$1.13

(Data provided by Zacks Investment Research)

Dividends

Dividend History for Illumina (NASDAQ:ILMN)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Illumina (NASDAQ:ILMN)

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Details
9/20/2016	Robert S Epstein	Director	Sell	300	$174.29	$52,287.00
9/15/2016	Marc Stapley	EVP	Sell	1,270	$172.87	$219,544.90
9/14/2016	Daniel Bradbury	Director	Sell	600	$171.25	$102,750.00
8/23/2016	Jay T Flatley	Director	Sell	20,000	$172.99	$3,459,800.00
8/22/2016	Robert S Epstein	Director	Sell	300	$170.27	$51,081.00
8/17/2016	Daniel Bradbury	Director	Sell	600	$168.42	$101,052.00
8/15/2016	Jay T Flatley	Director	Sell	10,000	$170.00	$1,700,000.00
8/12/2016	Roy A Whitfield	Director	Sell	4,000	$167.22	$668,880.00
8/9/2016	Jay T Flatley	Director	Sell	10,000	$165.97	$1,659,700.00
8/1/2016	Jay T Flatley	Director	Sell	10,000	$170.00	$1,700,000.00
7/27/2016	Charles Dadswell	SVP	Sell	8,632	$155.00	$1,337,960.00
7/26/2016	Jay T Flatley	Director	Sell	10,000	$150.00	$1,500,000.00
7/20/2016	Robert S Epstein	Director	Sell	1,200	$150.00	$180,000.00
7/18/2016	Jay T Flatley	Director	Sell	10,000	$150.00	$1,500,000.00
7/14/2016	A Blaine Bowman	Director	Sell	5,000	$147.14	$735,700.00
7/11/2016	Christian O Henry	EVP	Sell	716	$141.89	$101,593.24
6/16/2016	A Blaine Bowman	Director	Sell	5,000	$135.08	$675,400.00
6/15/2016	Christian O Henry	EVP	Sell	2,141	$137.90	$295,243.90
6/13/2016	Roy A Whitfield	Director	Sell	3,800	$140.44	$533,672.00
6/1/2016	Karin Eastham	Director	Sell	5,000	$145.35	$726,750.00
5/25/2016	Christian O Henry	EVP	Sell	2,141	$144.73	$309,866.93
5/17/2016	Christian O Henry	EVP	Sell	2,141	$140.84	$301,538.44
5/12/2016	A Blaine Bowman	Director	Sell	5,000	$137.11	$685,550.00
4/27/2016	Christian O Henry	EVP	Sell	2,141	$138.46	$296,442.86
4/18/2016	Christian O Henry	EVP	Sell	2,141	$176.01	$376,837.41
4/18/2016	Paul L Bianchi	VP	Sell	1,884	$175.00	$329,700.00
4/14/2016	A Blaine Bowman	Director	Sell	5,000	$172.94	$864,700.00
4/13/2016	Christian O Henry	EVP	Sell	12,500	$175.00	$2,187,500.00
4/13/2016	Paul L Bianchi	VP	Sell	6,681	$175.00	$1,169,175.00
4/12/2016	Jay T Flatley	CEO	Sell	20,000	$170.05	$3,401,000.00
4/12/2016	Roy A Whitfield	Director	Sell	4,000	$170.00	$680,000.00
4/7/2016	David R Walt	Director	Sell	4,000	$168.90	$675,600.00
4/5/2016	Christian O Henry	EVP	Sell	2,141	$166.07	$355,555.87
4/4/2016	Charles Dadswell	SVP	Sell	8,382	$167.81	$1,406,583.42
3/23/2016	Christian O Henry	EVP	Sell	2,141	$155.05	$331,962.05
3/22/2016	Jay T Flatley	CEO	Sell	10,000	$154.18	$1,541,800.00
3/21/2016	Daniel Bradbury	Director	Sell	1,200	$155.63	$186,756.00
3/21/2016	Nicholas Naclerio	SVP	Sell	4,520	$154.25	$697,210.00
3/17/2016	A Blaine Bowman	Director	Sell	5,000	$145.24	$726,200.00
3/15/2016	David R Walt	Director	Sell	4,000	$149.99	$599,960.00
3/14/2016	Christian O Henry	EVP	Sell	5,892	$155.91	$918,621.72
3/8/2016	Charles Dadswell	SVP	Sell	8,382	$155.63	$1,304,490.66
3/8/2016	Jay T Flatley	CEO	Sell	10,000	$154.49	$1,544,900.00
3/8/2016	Omead Ostadan	EVP	Sell	4,516	$156.09	$704,902.44
3/7/2016	Charles Dadswell	SVP	Sell	116	$155.00	$17,980.00
2/23/2016	Jay T Flatley	CEO	Sell	10,000	$152.49	$1,524,900.00
2/17/2016	Daniel Bradbury	Director	Sell	1,700	$154.74	$263,058.00
2/12/2016	Roy A. Whitfield	Director	Sell	3,750	$140.30	$526,125.00
2/1/2016	Omead Ostadan	EVP	Sell	1,108	$156.73	$173,656.84
1/26/2016	Jay T. Flatley	CEO	Sell	20,000	$171.70	$3,434,000.00
1/13/2016	Jay T. Flatley	CEO	Sell	20,000	$168.81	$3,376,200.00
1/4/2016	Daniel Bradbury	Director	Sell	1,700	$182.80	$310,760.00
12/28/2015	Charles Dadswell	SVP	Sell	168	$188.63	$31,689.84
12/22/2015	Jay T. Flatley	CEO	Sell	25,000	$185.38	$4,634,500.00
12/14/2015	Roy A. Whitfield	Director	Sell	3,750	$175.07	$656,512.50
12/11/2015	Omead Ostadan	EVP	Sell	260	$179.90	$46,774.00
12/11/2015	Paul L Bianchi	VP	Sell	197	$179.90	$35,440.30
12/10/2015	Daniel Bradbury	Director	Sell	1,700	$182.37	$310,029.00
12/8/2015	Jay T. Flatley	CEO	Sell	25,000	$177.11	$4,427,750.00
11/27/2015	Robert S Epstein	Director	Sell	1,000	$185.56	$185,560.00
11/25/2015	Jay T. Flatley	CEO	Sell	5,000	$180.00	$900,000.00
11/24/2015	Jay T. Flatley	CEO	Sell	20,000	$173.27	$3,465,400.00
11/16/2015	Jay T. Flatley	CEO	Sell	10,000	$170.00	$1,700,000.00
11/10/2015	Daniel Bradbury	Director	Sell	1,700	$154.03	$261,851.00
11/10/2015	Jay T. Flatley	CEO	Sell	10,000	$154.58	$1,545,800.00
11/3/2015	Charles Dadswell	SVP	Sell	158	$150.00	$23,700.00
10/15/2015	Jay T. Flatley	CEO	Sell	10,000	$150.00	$1,500,000.00
10/7/2015	Daniel Bradbury	Director	Sell	1,700	$145.81	$247,877.00
9/29/2015	David R Walt	Director	Sell	2,000	$171.65	$343,300.00
9/22/2015	Jay T. Flatley	CEO	Sell	25,000	$192.79	$4,819,750.00
9/15/2015	David R Walt	Director	Sell	2,000	$206.45	$412,900.00
9/14/2015	Daniel Bradbury	Director	Sell	1,700	$203.89	$346,613.00
9/9/2015	Paul L. Bianchi	VP	Sell	1,245	$199.32	$248,153.40
9/8/2015	Jay T. Flatley	CEO	Sell	25,000	$194.87	$4,871,750.00
9/8/2015	Karin Eastham	Director	Sell	4,300	$195.76	$841,768.00
9/4/2015	Roy A. Whitfield	Director	Sell	4,500	$192.63	$866,835.00
9/1/2015	David R Walt	Director	Sell	2,000	$195.08	$390,160.00
8/27/2015	Jay T. Flatley	CEO	Sell	25,000	$200.16	$5,004,000.00
8/18/2015	David R Walt	Director	Sell	2,000	$206.89	$413,780.00
8/17/2015	Daniel Bradbury	Director	Sell	1,700	$208.14	$353,838.00
8/13/2015	Jay T Flatley	CEO	Sell	25,000	$207.85	$5,196,250.00
8/5/2015	Roy A. Whitfield	Director	Sell	4,500	$215.22	$968,490.00
7/24/2015	A Blaine Bowman	Director	Sell	3,000	$221.47	$664,410.00
7/23/2015	Jay T Flatley	CEO	Sell	25,000	$214.87	$5,371,750.00
7/21/2015	David R Walt	Director	Sell	12,000	$235.24	$2,822,880.00
7/17/2015	Mostafa Ronaghi	SVP	Sell	1,200	$235.00	$282,000.00
7/16/2015	Christian O Henry	SVP	Sell	5,390	$229.61	$1,237,597.90
7/15/2015	Mostafa Ronaghi	SVP	Sell	3,000	$227.19	$681,570.00
7/14/2015	David R Walt	Director	Sell	10,000	$227.39	$2,273,900.00
7/13/2015	Marc Stapley	CFO	Sell	3,000	$214.90	$644,700.00
7/13/2015	Michel Bouchard	CAO	Sell	1,400	$222.75	$311,850.00
7/10/2015	Omead Ostadan	SVP	Sell	1,110	$219.81	$243,989.10
7/10/2015	Robert S Epstein	Director	Sell	2,000	$219.81	$439,620.00
7/9/2015	Jay T Flatley	CEO	Sell	25,000	$218.10	$5,452,500.00
7/7/2015	David R Walt	Director	Sell	10,000	$220.22	$2,202,200.00
7/6/2015	Daniel Bradbury	Director	Sell	1,700	$219.70	$373,490.00
6/30/2015	David R Walt	Director	Sell	10,000	$217.64	$2,176,400.00
6/25/2015	Jay T Flatley	CEO	Sell	25,000	$220.34	$5,508,500.00
6/24/2015	A Blaine Bowman	Director	Sell	3,000	$221.43	$664,290.00
6/24/2015	Christian O Henry	SVP	Sell	5,084	$221.07	$1,123,919.88
6/23/2015	David R Walt	Director	Sell	12,000	$220.11	$2,641,320.00
6/17/2015	Christian O Henry	SVP	Sell	3,751	$215.71	$809,128.21
6/16/2015	David R Walt	Director	Sell	10,000	$215.14	$2,151,400.00
6/15/2015	Nicholas Naclerio	SVP	Sell	6,590	$214.33	$1,412,434.70
6/15/2015	Paul L Bianchi	VP	Sell	3,408	$215.83	$735,548.64
6/12/2015	Marc Stapley	CFO	Sell	3,000	$214.90	$644,700.00
6/12/2015	Michel Bouchard	CAO	Sell	1,400	$216.11	$302,554.00
6/11/2015	Jay T Flatley	CEO	Sell	25,000	$216.41	$5,410,250.00
6/10/2015	Christian O Henry	SVP	Sell	10,000	$214.94	$2,149,400.00
6/10/2015	Robert S Epstein	Director	Sell	2,000	$214.24	$428,480.00
6/5/2015	Roy A Whitfield	Director	Sell	4,500	$207.49	$933,705.00
6/2/2015	David R Walt	Director	Sell	10,000	$204.42	$2,044,200.00
6/1/2015	Karin Eastham	Director	Sell	5,000	$205.24	$1,026,200.00
5/29/2015	Daniel Bradbury	Director	Sell	1,700	$206.62	$351,254.00
5/28/2015	Jay T Flatley	CEO	Sell	25,000	$208.78	$5,219,500.00
5/22/2015	A Blaine Bowman	Director	Sell	3,000	$204.58	$613,740.00
5/19/2015	David R Walt	Director	Sell	10,000	$202.00	$2,020,000.00
5/14/2015	Christian O Henry	SVP	Sell	3,751	$198.52	$744,648.52
5/14/2015	Jay T Flatley	CEO	Sell	25,000	$197.76	$4,944,000.00
5/13/2015	Paul L Bianchi	VP	Sell	3,356	$197.14	$661,601.84
5/11/2015	Robert S Epstein	Director	Sell	2,000	$196.49	$392,980.00
4/28/2015	David R Walt	Director	Sell	7,000	$183.88	$1,287,160.00
4/24/2015	A Blaine Bowman	Director	Sell	3,000	$190.73	$572,190.00
4/23/2015	Jay T Flatley	CEO	Sell	25,000	$189.57	$4,739,250.00
4/21/2015	David R Walt	Director	Sell	10,000	$197.95	$1,979,500.00
4/15/2015	Christian O Henry	SVP	Sell	3,751	$189.02	$709,014.02
4/14/2015	David R Walt	Director	Sell	7,000	$188.23	$1,317,610.00
4/13/2015	Marc Stapley	CFO	Sell	3,000	$190.12	$570,360.00
4/13/2015	Michel Bouchard	CAO	Sell	1,400	$188.61	$264,054.00
4/13/2015	Paul L Bianchi	VP	Sell	3,390	$187.22	$634,675.80
4/10/2015	Robert S Epstein	Director	Sell	2,000	$186.99	$373,980.00
4/9/2015	Jay T Flatley	CEO	Sell	25,000	$184.55	$4,613,750.00
4/8/2015	Daniel Bradbury	Director	Sell	1,700	$185.32	$315,044.00
4/7/2015	David R Walt	Director	Sell	5,000	$184.28	$921,400.00
4/6/2015	Roy A Whitfield	Director	Sell	4,600	$181.32	$834,072.00
3/26/2015	Jay T Flatley	CEO	Sell	25,000	$181.34	$4,533,500.00
3/24/2015	David R Walt	Director	Sell	5,000	$192.16	$960,800.00
3/17/2015	A Blaine Bowman	Director	Sell	3,000	$192.30	$576,900.00
3/16/2015	Gerald Moeller	Director	Sell	2,700	$193.36	$522,072.00
3/16/2015	Nicholas Naclerio	SVP	Sell	6,590	$193.94	$1,278,064.60
3/13/2015	Paul L Bianchi	VP	Sell	3,390	$186.67	$632,811.30
3/12/2015	Marc Stapley	CFO	Sell	3,314	$189.01	$626,379.14
3/10/2015	Richard Klausner	SVP	Sell	1,186	$191.75	$227,415.50
3/10/2015	Robert S Epstein	Director	Sell	3,000	$191.75	$575,250.00
2/26/2015	Jay T Flatley	CEO	Sell	25,000	$195.73	$4,893,250.00
2/12/2015	Jay T Flatley	CEO	Sell	25,000	$194.64	$4,866,000.00
2/3/2015	David R Walt	Director	Sell	7,000	$190.89	$1,336,230.00
2/2/2015	Karin Eastham	Director	Sell	10,000	$192.77	$1,927,700.00
2/2/2015	Nicholas Naclerio	SVP	Sell	15,250	$194.37	$2,964,142.50
1/27/2015	Charles Dadswell	SVP	Sell	224	$198.90	$44,553.60
1/27/2015	David R Walt	Director	Sell	4,000	$201.76	$807,040.00
1/22/2015	Jay T Flatley	CEO	Sell	25,000	$188.48	$4,712,000.00
1/20/2015	William H Rastetter	Director	Sell	16,000	$188.99	$3,023,840.00
1/15/2015	Marc Stapley	CFO	Sell	1,422	$181.62	$258,263.64
1/8/2015	Jay T Flatley	CEO	Sell	25,000	$197.62	$4,940,500.00
1/6/2015	David R Walt	Director	Sell	6,000	$188.55	$1,131,300.00
1/2/2015	Karin Eastham	Director	Sell	10,000	$185.63	$1,856,300.00
12/30/2014	David R Walt	Director	Sell	5,000	$186.95	$934,750.00
12/29/2014	Gerald Moeller	Director	Sell	8,000	$187.05	$1,496,400.00
12/26/2014	Jay T Flatley	CEO	Sell	25,000	$186.71	$4,667,750.00
12/23/2014	David R Walt	Director	Sell	7,000	$184.55	$1,291,850.00
12/16/2014	David R Walt	Director	Sell	5,000	$178.35	$891,750.00
12/15/2014	Marc Stapley	CFO	Sell	1,422	$181.09	$257,509.98
12/11/2014	Jay T Flatley	CEO	Sell	25,000	$185.79	$4,644,750.00
12/9/2014	David R Walt	Director	Sell	7,000	$186.75	$1,307,250.00
12/8/2014	Daniel Bradbury	Director	Sell	1,600	$190.14	$304,224.00
12/4/2014	Karin Eastham	Director	Sell	10,000	$191.87	$1,918,700.00
12/1/2014	Mostafa Ronaghi	SVP	Sell	10,000	$188.46	$1,884,600.00
11/26/2014	Paul L Bianchi	SVP	Sell	1,626	$189.20	$307,639.20
11/17/2014	Roy A Whitfield	Director	Sell	4,000	$178.26	$713,040.00
11/14/2014	Marc Stapley	CFO	Sell	1,422	$181.13	$257,566.86
11/13/2014	Daniel Bradbury	Director	Sell	2,100	$186.88	$392,448.00
11/13/2014	Jay T Flatley	CEO	Sell	25,000	$189.32	$4,733,000.00
11/3/2014	Michel Bouchard	CAO	Sell	631	$195.68	$123,474.08
11/3/2014	Mostafa Ronaghi	SVP	Sell	10,000	$195.66	$1,956,600.00
10/30/2014	Daniel Bradbury	Director	Sell	2,100	$191.83	$402,843.00
10/23/2014	Jay T Flatley	CEO	Sell	25,000	$189.54	$4,738,500.00
10/13/2014	Daniel Bradbury	Director	Sell	2,100	$152.03	$319,263.00
10/9/2014	Jay T Flatley	CEO	Sell	25,000	$163.49	$4,087,250.00
10/7/2014	A Blaine Bowman	Director	Sell	4,456	$159.51	$710,776.56
10/1/2014	Daniel Bradbury	Director	Sell	2,100	$158.88	$333,648.00
10/1/2014	Mostafa Ronaghi	SVP	Sell	10,000	$159.81	$1,598,100.00
9/30/2014	A Blaine Bowman	Director	Sell	5,000	$164.02	$820,100.00
9/29/2014	Gerald Moeller	Director	Sell	5,000	$164.89	$824,450.00
9/25/2014	Jay T Flatley	CEO	Sell	25,000	$164.43	$4,110,750.00
9/24/2014	Christian O Henry	SVP	Sell	20,000	$167.28	$3,345,600.00
9/23/2014	A Blaine Bowman	Director	Sell	5,000	$168.50	$842,500.00
9/16/2014	A Blaine Bowman	Director	Sell	5,000	$169.60	$848,000.00
9/15/2014	Daniel Bradbury	Director	Sell	2,100	$168.57	$353,997.00
9/15/2014	Jay T Flatley	CEO	Sell	25,000	$176.06	$4,401,500.00
9/15/2014	Marc Stapley	CFO	Sell	1,422	$169.05	$240,389.10
9/15/2014	Nicholas Naclerio	SVP	Sell	2,000	$169.53	$339,060.00
9/9/2014	A Blaine Bowman	Director	Sell	5,000	$178.08	$890,400.00
9/3/2014	Christian O Henry	SVP	Sell	10,000	$180.59	$1,805,900.00
9/3/2014	Daniel Bradbury	Director	Sell	2,100	$179.77	$377,517.00
9/2/2014	A Blaine Bowman	Director	Sell	5,000	$179.67	$898,350.00
9/2/2014	Michel Bouchard	VP	Sell	686	$180.07	$123,528.02
9/2/2014	Mostafa Ronaghi	SVP	Sell	10,000	$179.66	$1,796,600.00
8/28/2014	Jay T Flatley	CEO	Sell	30,000	$178.98	$5,369,400.00
8/26/2014	A Blaine Bowman	Director	Sell	5,000	$179.22	$896,100.00
8/22/2014	Daniel Bradbury	Director	Sell	2,100	$172.24	$361,704.00
8/19/2014	A Blaine Bowman	Director	Sell	5,000	$171.70	$858,500.00
8/15/2014	Nicholas Naclerio	SVP	Sell	2,000	$167.23	$334,460.00
8/15/2014	Roy A Whitfield	Director	Sell	4,000	$169.28	$677,120.00
8/13/2014	Christian O Henry	SVP	Sell	20,000	$164.66	$3,293,200.00
8/5/2014	A Blaine Bowman	Director	Sell	5,000	$159.91	$799,550.00
8/4/2014	Daniel Bradbury	Director	Sell	2,100	$159.77	$335,517.00
8/1/2014	Mostafa Ronaghi	SVP	Sell	10,000	$159.73	$1,597,300.00
7/29/2014	A Blaine Bowman	Director	Sell	5,000	$166.89	$834,450.00
7/29/2014	Christian O Henry	SVP	Sell	10,000	$167.40	$1,674,000.00
7/24/2014	Jay T Flatley	CEO	Sell	30,000	$175.43	$5,262,900.00
7/23/2014	Daniel Bradbury	Director	Sell	2,100	$177.87	$373,527.00
7/15/2014	Nicholas Naclerio	SVP	Sell	2,000	$174.26	$348,520.00
7/14/2014	Marc Stapley	CFO	Sell	1,422	$177.59	$252,532.98
7/10/2014	Jay T Flatley	CEO	Sell	30,000	$172.56	$5,176,800.00
7/8/2014	Daniel Bradbury	Director	Sell	2,100	$172.89	$363,069.00
7/1/2014	Mostafa Ronaghi	SVP	Sell	10,000	$179.47	$1,794,700.00
6/30/2014	Gerald Moeller	Director	Sell	5,000	$178.97	$894,850.00
6/27/2014	Daniel Bradbury	Director	Sell	2,100	$171.65	$360,465.00
6/26/2014	Jay T Flatley	CEO	Sell	30,000	$170.11	$5,103,300.00
6/24/2014	Christian O Henry	SVP	Sell	10,000	$172.60	$1,726,000.00
6/16/2014	Christian O Henry	SVP	Sell	20,000	$169.73	$3,394,600.00
6/16/2014	Marc Stapley	CFO	Sell	1,422	$169.25	$240,673.50
6/12/2014	Daniel Bradbury	Director	Sell	2,100	$171.17	$359,457.00
6/12/2014	Jay T Flatley	CEO	Sell	30,000	$172.25	$5,167,500.00
6/2/2014	Karin Eastham	Director	Sell	6,000	$157.56	$945,360.00
6/2/2014	Michel Bouchard	CAO	Sell	1,491	$155.51	$231,865.41
6/2/2014	Mostafa Ronaghi	SVP	Sell	10,000	$156.93	$1,569,300.00
5/22/2014	Jay Flatley	CEO	Sell	30,000	$154.95	$4,648,500.00
5/15/2014	Nicholas Naclerio	SVP	Sell	2,000	$141.72	$283,440.00
5/15/2014	Roy Whitfield	Director	Sell	4,000	$143.71	$574,840.00
5/14/2014	Daniel Bradbury	Director	Sell	2,100	$146.46	$307,566.00
5/14/2014	Marc Stapley	CFO	Sell	1,422	$146.94	$208,948.68
5/8/2014	Jay Flatley	CEO	Sell	30,000	$143.59	$4,307,700.00
5/2/2014	Daniel Bradbury	Director	Sell	2,100	$139.66	$293,286.00
5/1/2014	Mostafa Ronaghi	SVP	Sell	10,000	$135.91	$1,359,100.00
4/24/2014	Jay Flatley	CEO	Sell	30,000	$150.80	$4,524,000.00
4/15/2014	Daniel Bradbury	Director	Sell	2,100	$131.29	$275,709.00
4/15/2014	Nicholas Naclerio	SVP	Sell	2,000	$133.56	$267,120.00
4/14/2014	Marc Stapley	CFO	Sell	1,422	$134.80	$191,685.60
4/10/2014	Jay Flatley	CEO	Sell	30,000	$139.90	$4,197,000.00
4/4/2014	Daniel Bradbury	Director	Sell	2,100	$138.44	$290,724.00
4/1/2014	Mostafa Ronaghi	SVP	Sell	10,000	$152.41	$1,524,100.00
3/27/2014	Jay Flatley	CEO	Sell	30,000	$140.11	$4,203,300.00
3/19/2014	Daniel Bradbury	Director	Sell	2,100	$161.14	$338,394.00
3/17/2014	Gerald Moeller	Director	Sell	10,000	$161.92	$1,619,200.00
3/17/2014	Nicholas Naclerio	SVP	Sell	2,000	$163.65	$327,300.00
3/14/2014	Marc Stapley	CFO	Sell	1,422	$163.35	$232,283.70
3/13/2014	Jay Flatley	CEO	Sell	30,000	$165.96	$4,978,800.00
3/11/2014	Christian Henry	SVP	Sell	3,000	$167.16	$501,480.00
3/11/2014	Michel Bouchard	CAO	Sell	2,168	$167.21	$362,511.28
3/3/2014	Michel Bouchard	CAO	Sell	2,994	$176.81	$529,369.14
2/25/2014	Michel Bouchard	CAO	Sell	24,505	$176.13	$4,316,065.65
2/24/2014	Roy Whitfield	Director	Sell	2,000	$175.26	$350,520.00
2/18/2014	Nicholas Naclerio	SVP	Sell	2,000	$169.77	$339,540.00
2/13/2014	Jay Flatley	CEO	Sell	30,000	$160.43	$4,812,900.00
2/7/2014	Jay Flatley	CEO	Sell	5,000	$152.23	$761,150.00
1/31/2014	Marc Stapley	CFO	Sell	20,038	$151.32	$3,032,150.16
1/23/2014	Jay Flatley	CEO	Sell	30,000	$142.30	$4,269,000.00
1/9/2014	Jay Flatley	CEO	Sell	30,000	$114.77	$3,443,100.00
12/26/2013	Jay Flatley	CEO	Sell	30,000	$107.88	$3,236,400.00
12/17/2013	Gregory Heath	SVP	Sell	1,875	$102.68	$192,525.00
10/30/2013	Christian O Henry	SVP	Sell	6,000	$93.29	$559,740.00
10/30/2013	David R Walt	Director	Sell	5,000	$93.02	$465,100.00
10/28/2013	William H Rastetter	Director	Sell	20,000	$92.37	$1,847,400.00
10/24/2013	Jay T Flatley	CEO	Sell	30,000	$92.32	$2,769,600.00
10/22/2013	Nicholas Naclerio	SVP	Sell	20,000	$90.00	$1,800,000.00
10/17/2013	Gregory Heath	SVP	Sell	1,875	$82.09	$153,918.75
10/16/2013	David R Walt	Director	Sell	5,000	$82.59	$412,950.00
10/15/2013	Nicholas Naclerio	SVP	Sell	4,000	$81.32	$325,280.00
10/10/2013	Christian Henry	SVP	Sell	6,000	$77.73	$466,380.00
10/10/2013	Jay Flatley	CEO	Sell	20,000	$77.75	$1,555,000.00
10/2/2013	David R Walt	Director	Sell	5,000	$80.58	$402,900.00
9/18/2013	David Walt	Director	Sell	5,000	$83.11	$415,550.00
9/17/2013	Gregory Heath	SVP	Sell	1,875	$85.20	$159,750.00
9/16/2013	Jay Flatley	CEO	Sell	30,000	$83.27	$2,498,100.00
9/16/2013	Nicholas Naclerio	SVP	Sell	4,000	$85.00	$340,000.00
9/10/2013	Gregory Heath	SVP	Sell	1,875	$82.00	$153,750.00
9/9/2013	Paul L Bianchi	SVP	Sell	1,627	$79.03	$128,581.81
9/5/2013	Christian O Henry	SVP	Sell	9,000	$78.17	$703,530.00
9/4/2013	David R Walt	Director	Sell	5,000	$77.18	$385,900.00
9/3/2013	Nicholas Naclerio	SVP	Sell	59,000	$76.91	$4,537,690.00
9/3/2013	Roy A Whitfield	Director	Sell	2,000	$78.49	$156,980.00
8/30/2013	Mark Lewis	SVP	Sell	5,000	$78.12	$390,600.00
8/22/2013	Jay Flatley	CEO	Sell	20,000	$78.65	$1,573,000.00
8/21/2013	David Walt	Director	Sell	5,000	$78.34	$391,700.00
8/15/2013	Nicholas Naclerio	SVP	Sell	2,000	$78.43	$156,860.00
8/8/2013	Jay Flatley	CEO	Sell	20,000	$78.07	$1,561,400.00
8/7/2013	David Walt	Director	Sell	5,000	$78.29	$391,450.00
8/2/2013	Michel Bouchard	VP	Sell	11,465	$80.64	$924,537.60
7/25/2013	Christian O Henry	SVP	Sell	11,462	$80.89	$927,161.18
7/25/2013	Jay T Flatley	CEO	Sell	20,000	$81.01	$1,620,200.00
7/24/2013	David R Walt	Director	Sell	4,600	$81.44	$374,624.00
7/24/2013	Gregory Heath	SVP	Sell	209,533	$82.00	$17,181,706.00
7/24/2013	Michel Bouchard	VP	Sell	9,789	$79.28	$776,071.92
7/15/2013	Nicholas Naclerio	SVP	Sell	2,000	$74.50	$149,000.00
7/11/2013	Jay T Flatley	CEO	Sell	20,000	$74.90	$1,498,000.00
7/11/2013	Mostafa Ronaghi	SVP	Sell	24,000	$74.95	$1,798,800.00
7/10/2013	David R Walt	Director	Sell	5,000	$74.26	$371,300.00
7/10/2013	Michel Bouchard	VP	Sell	3,618	$74.30	$268,817.40
7/9/2013	Christian O Henry	SVP	Sell	9,000	$74.01	$666,090.00
6/27/2013	Jay T Flatley	CEO	Sell	20,000	$74.96	$1,499,200.00
6/26/2013	David R Walt	Director	Sell	5,000	$75.36	$376,800.00
6/26/2013	Michel Bouchard	VP	Sell	4,272	$75.06	$320,656.32
6/25/2013	Tristan Orpin	SVP	Sell	35,000	$71.98	$2,519,300.00
6/17/2013	Nicholas Naclerio	SVP	Sell	2,000	$68.56	$137,120.00
6/14/2013	Christian O Henry	SVP	Sell	25,959	$68.10	$1,767,807.90
6/13/2013	Jay T Flatley	CEO	Sell	20,000	$66.49	$1,329,800.00
6/13/2013	Tristan Orpin	SVP	Sell	47,667	$66.55	$3,172,238.85
6/12/2013	David R Walt	Director	Sell	5,000	$67.67	$338,350.00
6/12/2013	Michel Bouchard	VP	Sell	5,170	$68.64	$354,868.80
6/11/2013	Mostafa Ronaghi	SVP	Sell	24,000	$69.01	$1,656,240.00
6/3/2013	Karin Eastham	Director	Sell	10,000	$70.34	$703,400.00
5/31/2013	Mark L Lewis	SVP	Sell	13,000	$71.72	$932,360.00
5/30/2013	Matthew L Posard	SVP	Sell	2,836	$70.80	$200,788.80
5/29/2013	David R Walt	Director	Sell	5,000	$70.92	$354,600.00
5/29/2013	Michel Bouchard	VP	Sell	6,276	$71.02	$445,721.52
5/21/2013	Jay T Flatley	CEO	Sell	24,000	$69.39	$1,665,360.00
5/20/2013	Marc Stapley	CFO	Sell	2,843	$73.38	$208,619.34
5/15/2013	David R Walt	Director	Sell	5,000	$70.73	$353,650.00
5/15/2013	Michel Bouchard	VP	Sell	14,241	$70.71	$1,006,981.11
5/15/2013	Nicholas Naclerio	SVP	Sell	2,000	$70.72	$141,440.00
5/13/2013	Mostafa Ronaghi	SVP	Sell	24,000	$68.83	$1,651,920.00
5/10/2013	Tristan Orpin	SVP	Sell	25,000	$69.60	$1,740,000.00
5/9/2013	Jay T Flatley	CEO	Sell	20,000	$66.63	$1,332,600.00
5/7/2013	Tristan Orpin	SVP	Sell	5,000	$65.68	$328,400.00
4/8/2013	Christian Cabou	SVP	Sell	16,500	$55.00	$907,500.00
4/8/2013	Marc Stapley	CFO	Sell	9,175	$55.00	$504,625.00
4/8/2013	William H Rastetter	Director	Sell	20,000	$54.95	$1,099,000.00
3/11/2013	Marc Stapley	CFO	Sell	4,468	$53.71	$239,976.28
11/8/2012	Jay T Flatley	CEO	Sell	5,000	$47.99	$239,950.00

(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Illumina (NASDAQ:ILMN)

Date	Headline
	Biotech Stocks Worth a Closer Look: Biogen Inc. (NASDAQ:BIIB), Illumina Inc. (NASDAQ:ILMN) - The Voice Registrar (NASDAQ:ILMN) voiceregistrar.com - September 26 at 5:42 PM
	Illumina Inc. (NASDAQ:ILMN) Upcoming Earnings: What matter for investors? - The Voice Registrar (NASDAQ:ILMN) voiceregistrar.com - September 26 at 5:42 PM
	Illumina, Inc. (NASDAQ:ILMN)'s Accounts Payable Is $250.67 - RealistInvestor.com (NASDAQ:ILMN) www.realistinvestor.com - September 24 at 5:11 PM
	Noteworthy Thursday Option Activity: ILMN, FSLR, FLR (NASDAQ:ILMN) www.forbes.com - September 22 at 3:31 PM
	Hot Biotech Stocks Recap: Ocular Therapeutix, Inc. (NASDAQ:OCUL), Illumina Inc. (NASDAQ:ILMN) - The Voice Registrar (NASDAQ:ILMN) voiceregistrar.com - September 22 at 8:47 AM
	Commit To Buy Illumina At $105, Earn 4.3% Using Options (NASDAQ:ILMN) www.nasdaq.com - September 21 at 9:47 AM
	Leading stocks in today’s market: Illumina Inc. (NASDAQ:ILMN) (NASDAQ:ILMN) twincountynews.com - September 21 at 9:47 AM
	2 Biotech Stocks News And Price Trends: Illumina Inc. (NASDAQ:ILMN), PTC Therapeutics, Inc. (NASDAQ:PTCT) - The Voice Registrar (NASDAQ:ILMN) voiceregistrar.com - September 19 at 10:08 AM
	Illumina, Inc. (NASDAQ:ILMN) Is Expected To Post EPS Of $1.05 - RealistInvestor.com (NASDAQ:ILMN) www.realistinvestor.com - September 16 at 9:32 AM
	Market Focus: Checking on Session Activity for Illumina, Inc. (NASDAQ:ILMN) Shares - Post News (NASDAQ:ILMN) www.kentuckypostnews.com - September 12 at 5:28 PM
	Biotech news that matter for investors: Exelixis, Inc. (NASDAQ:EXEL), Illumina Inc. (NASDAQ:ILMN) - The Voice Registrar (NASDAQ:ILMN) voiceregistrar.com - September 12 at 5:28 PM
	Update on Illumina Inc. (NASDAQ:ILMN) for the day (NASDAQ:ILMN) twincountynews.com - September 11 at 9:53 AM
	A Price Target Of $152.1 Is Set By Research Analysts For Illumina, Inc. (NASDAQ:ILMN) (NASDAQ:ILMN) www.realistinvestor.com - September 10 at 5:08 PM
	Today's Top Gainers in the Market Illumina Inc. (NASDAQ:ILMN ... - The Daily Leicester (NASDAQ:ILMN) thedailyleicester.com - September 10 at 10:00 AM
	Is Illumina Inc.(NASDAQ: ILMN), a large market cap stock a smart buy? - The Daily Leicester (NASDAQ:ILMN) thedailyleicester.com - September 10 at 10:00 AM
	HC Stocks Outlines= Illumina, Inc. (ILMN), MannKind Corporation (NASDAQ:MNKD) - share market updates (press release) (NASDAQ:ILMN) sharemarketupdates.com - September 8 at 5:29 PM
	Illumina Faces a Bumpy Ride for a Few Quarters (NASDAQ:ILMN) realmoney.thestreet.com - September 8 at 9:32 AM
	Today's Top Gainers in the Market Illumina Inc. (NASDAQ:ILMN) from Healthcare - The Daily Leicester (NASDAQ:ILMN) thedailyleicester.com - September 7 at 9:02 AM
	Which way Illumina Inc. (NASDAQ:ILMN) earnings may go - The Voice Registrar (NASDAQ:ILMN) voiceregistrar.com - September 2 at 5:32 PM
	A look at a High Market Cap Stock: Illumina Inc., ILMN - The Daily Leicester (NASDAQ:ILMN) thedailyleicester.com - September 2 at 10:26 AM
	Crowd Ratings & Broker Views on Illumina, Inc. (NASDAQ:ILMN)? - Post News (NASDAQ:ILMN) www.kentuckypostnews.com - August 30 at 8:49 AM
	Illumina to Webcast Live Presentation at the Morgan Stanley Global Healthcare Conference (NASDAQ:ILMN) finance.yahoo.com - August 30 at 8:49 AM
	Thermo Fisher to Buy Illumina? Not So Fast (NASDAQ:ILMN) www.fool.com - August 29 at 9:13 AM
	Friday Sector Leaders: Technology & Communications, Healthcare (NASDAQ:ILMN) www.forbes.com - August 26 at 5:28 PM
	Friday Sector Leaders: Technology & Communications, Healthcare (NASDAQ:ILMN) www.forbes.com - August 26 at 5:28 PM
	What’s behind Thermo Fisher’s Rumored Acquisition of Illumina? (NASDAQ:ILMN) marketrealist.com - August 26 at 8:36 AM
	Illumina Deserves Its Valuation - Seeking Alpha (NASDAQ:ILMN) seekingalpha.com - August 25 at 5:38 PM
	Share Price Estimates and Notable Insider Trading: Illumina, Inc. (NASDAQ:ILMN) - Post Registrar (NASDAQ:ILMN) postregistrar.com - August 25 at 5:38 PM
	Biotech building on the Peninsula bounces back — and it needs space to grow (NASDAQ:ILMN) feeds.bizjournals.com - August 25 at 3:13 PM
	Illumina Inc. (NASDAQ:ILMN) from Biotechnology – Todays Top Gains (NASDAQ:ILMN) twincountynews.com - August 24 at 5:30 PM
	Time To Put On The Watch List? - Illumina Inc. (NASDAQ:ILMN), Celldex Therapeutics, Inc. (NASDAQ:CLDX) - The Voice Registrar (NASDAQ:ILMN) voiceregistrar.com - August 22 at 5:41 PM
	Illumina downgraded by CL King (NASDAQ:ILMN) finance.yahoo.com - August 22 at 5:41 PM
	Analysts Valuations For Two Stocks: Illumina, Inc. (NASDAQ:ILMN), Hormel Foods Corp (NYSE:HRL) - The Voice Registrar (NASDAQ:ILMN) voiceregistrar.com - August 19 at 5:37 PM
	Illumina, Inc. (ILMN) Stake Increased by Schwab Charles Investment Management Inc - Finance Daily (NASDAQ:ILMN) www.fidaily.com - August 18 at 5:39 PM
	Illumina, Inc. (ILMN) Receives $30 Billion Offer From Thermo Fisher: Sources - Bidness ETC (NASDAQ:ILMN) www.bidnessetc.com - August 18 at 5:38 PM
	Illumina Gains on Report of $30 Billion Offer From Thermo Fisher (NASDAQ:ILMN) finance.yahoo.com - August 18 at 5:38 PM
	Illumina Gains on Report of $30 Billion Thermo Fisher Offer (NASDAQ:ILMN) www.bloomberg.com - August 18 at 5:38 PM
	Illumina: Takeover Speculation 'Makes No Sense' (NASDAQ:ILMN) blogs.barrons.com - August 18 at 5:38 PM
	Illumina: Back in Bidness? (NASDAQ:ILMN) www.bloomberg.com - August 18 at 5:38 PM
	Illumina Pops on Takeover -- One Chart Gives it Perspective (NASDAQ:ILMN) finance.yahoo.com - August 18 at 5:38 PM
	Illumina (ILMN) Stock Gains on Thermo Fisher Takeover Speculation (NASDAQ:ILMN) www.thestreet.com - August 18 at 5:38 PM
	Illumina Shares Gain 2%, Cooling Speculation of a Thermo Fisher Buyout (NASDAQ:ILMN) www.thestreet.com - August 18 at 5:38 PM
	Will Thermo Fisher Buy Illumina? Analyst Sees 'Close To A 0%' Chance (NASDAQ:ILMN) www.investors.com - August 18 at 5:38 PM
	Thermo Fisher rumored to make $30B bid for Illumina (NASDAQ:ILMN) seekingalpha.com - August 18 at 10:41 AM
	Top Gainers of the Day: Illumina Inc. (NASDAQ:ILMN) from Biotechnology (NASDAQ:ILMN) twincountynews.com - August 17 at 5:50 PM
	Ron Baron's Baron Funds Quarterly Report (NASDAQ:ILMN) finance.yahoo.com - August 17 at 5:50 PM
	Trading the Biotech News: Illumina Inc. (NASDAQ:ILMN), Immunomedics Inc. (NASDAQ:IMMU) - The Voice Registrar (NASDAQ:ILMN) voiceregistrar.com - August 17 at 8:41 AM
	ETF’s with exposure to Illumina, Inc. : August 16, 2016 (NASDAQ:ILMN) www.capitalcube.com - August 16 at 5:46 PM
	Illumina, Inc. (ILMN) Stake Up in Latest Report from Legal & General Group Plc - Finance Daily (NASDAQ:ILMN) www.fidaily.com - August 16 at 11:49 AM
	Notable Monday Option Activity: ILMN, MSFT, AKAM (NASDAQ:ILMN) www.forbes.com - August 15 at 2:38 PM

Social

Illumina (NASDAQ:ILMN) Chart for Tuesday, September, 27, 2016